Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFC vs Fluoxetine for Relapse Prevention in TRD
NCT00958568Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of olanzapine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Aug 2009; status: completed.
02
Drugs
olanzapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00958568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958568.